REFERENCES BIBLIOGRAPHIQUES
~ 47 ~
[125] DIPIETRO, L.A. (1995). Wound-Healing. The Role of the Macrophage and Other Immune Cells,
Shock. Tom 4. pp 233-240.
[126]SATO, A. AND IWASAKI, A. (2004). "Induction of antiviral immunity requires Toll-like receptor
signaling in both stroma land dendritic cell compartments." PNAS. 101 p.
[127]GLUCKMAN, J. C. (2004). "Les cellules présentatrices de l’antigène." Inserm EMI-0013 et
Laboratoire d’Immunologie Cellulaire et Immunopathologie de l’EPHE Conférence.
[128]FISCHER, H. G. AND BLIELINSKY, A. K. (1999). "Antigen presentation function of brain
deriveddendriform cells depends on astrocyte help." International Immunology. tom 11. pp 1265-1274.
[129]BIVAS-BENITA et al. (2004). "Pulmonary delivery of chitosan-DNA nanoparticles enhances the
immunogenicity of a DNA vaccine encoding HLA-A*0201-restricted T-cell epitopes of Mycobacterium
tuberculosis." Vaccine. 22 p.
[130]BABENSEE, J. E. AND PARANJPE, A. (2005). "Differential levels of dendritic cell maturation
on different biomaterials used in combination products." J Biomed Mater Res A 74(4). pp 503-510.
[131]BE Portugal numéro 56 (10/12/2012) - Ambassade de France au Portugal / ADIT(en ligne).
(Consulter
le
20/09/2014).
Disponible
à
l’adresse.
[132]Liang et al. (2007)."The antitumor activity of the hydrolysates of chitinous materials hydrolyzed
by crude enzyme from Bacillus amyloliquefaciens V656". Process Biochemistry. Tom 42. pp 527-534.
[133]Quin et al. (2002). «Enzymic preparation of water- soluble chitosan and their antitumor activity".
International Journal of Biological Macromolecules. tom31. pp 111-117.
[134]Pospieszny, H. Chirkov, S. Atabekov, 1. (1991). "Induction of antiviral resistance in plants by
chitosane".Plant Science. pp 63-68.
[135]Bacon et al. (2000). "Carbohydrate Biopolymers Enhance Antibody Responses to Mucosally
Delivered Vaccine Antigens". Infection and Immunity. 68 p.
[136]Gama Sosa et al. (1991). "N-carboxymethylchitosan-N, O-sulfate as an anti-HIV-1 agent".
Biochemical and Biophysical Research Communications. pp 489-496.
[137]Kochkina, Z.M. Chirkov, S.N. (2000). "Effect of chitosan derivatives on the Reproduction of
coliphages T2 and TT'.Mikrobiologiya. pp 257-260.
[138]VINCENT, M. (2009). Vectorisation, clé de l'efficacité des actifs. Parfums et cosmétiques
actualités. pp 115-126.
[139]BENITA, S. (2003). Microencapsulation : methods and industrial apllications. CRC Press.
[140]WHERLE, P. (2007). Pharmacie galénique : formulation et technologie pharmaceutique. Paris :
Maloine.
[141]CAMUZAT et al. (2008). Les sphérulites, la vectorisation flexible. Parfums et cosmétiques
actualités. pp 81-83.
~ 47 ~
[125] DIPIETRO, L.A. (1995). Wound-Healing. The Role of the Macrophage and Other Immune Cells,
Shock. Tom 4. pp 233-240.
[126]SATO, A. AND IWASAKI, A. (2004). "Induction of antiviral immunity requires Toll-like receptor
signaling in both stroma land dendritic cell compartments." PNAS. 101 p.
[127]GLUCKMAN, J. C. (2004). "Les cellules présentatrices de l’antigène." Inserm EMI-0013 et
Laboratoire d’Immunologie Cellulaire et Immunopathologie de l’EPHE Conférence.
[128]FISCHER, H. G. AND BLIELINSKY, A. K. (1999). "Antigen presentation function of brain
deriveddendriform cells depends on astrocyte help." International Immunology. tom 11. pp 1265-1274.
[129]BIVAS-BENITA et al. (2004). "Pulmonary delivery of chitosan-DNA nanoparticles enhances the
immunogenicity of a DNA vaccine encoding HLA-A*0201-restricted T-cell epitopes of Mycobacterium
tuberculosis." Vaccine. 22 p.
[130]BABENSEE, J. E. AND PARANJPE, A. (2005). "Differential levels of dendritic cell maturation
on different biomaterials used in combination products." J Biomed Mater Res A 74(4). pp 503-510.
[131]BE Portugal numéro 56 (10/12/2012) - Ambassade de France au Portugal / ADIT(en ligne).
(Consulter
le
20/09/2014).
Disponible
à
l’adresse
[132]Liang et al. (2007)."The antitumor activity of the hydrolysates of chitinous materials hydrolyzed
by crude enzyme from Bacillus amyloliquefaciens V656". Process Biochemistry. Tom 42. pp 527-534.
[133]Quin et al. (2002). «Enzymic preparation of water- soluble chitosan and their antitumor activity".
International Journal of Biological Macromolecules. tom31. pp 111-117.
[134]Pospieszny, H. Chirkov, S. Atabekov, 1. (1991). "Induction of antiviral resistance in plants by
chitosane".Plant Science. pp 63-68.
[135]Bacon et al. (2000). "Carbohydrate Biopolymers Enhance Antibody Responses to Mucosally
Delivered Vaccine Antigens". Infection and Immunity. 68 p.
[136]Gama Sosa et al. (1991). "N-carboxymethylchitosan-N, O-sulfate as an anti-HIV-1 agent".
Biochemical and Biophysical Research Communications. pp 489-496.
[137]Kochkina, Z.M. Chirkov, S.N. (2000). "Effect of chitosan derivatives on the Reproduction of
coliphages T2 and TT'.Mikrobiologiya. pp 257-260.
[138]VINCENT, M. (2009). Vectorisation, clé de l'efficacité des actifs. Parfums et cosmétiques
actualités. pp 115-126.
[139]BENITA, S. (2003). Microencapsulation : methods and industrial apllications. CRC Press.
[140]WHERLE, P. (2007). Pharmacie galénique : formulation et technologie pharmaceutique. Paris :
Maloine.
[141]CAMUZAT et al. (2008). Les sphérulites, la vectorisation flexible. Parfums et cosmétiques
actualités. pp 81-83.